The November 2021 Infrastructure Investment and Jobs Act (IIJA) requires manufacturers of separately paid, single use/single dose container Part B drugs and biologics to provide rebates for discarded units above a 10% threshold of separately paid spending for these products. Refunds apply to quarters beginning January 1, 2023. CMS is expected to issue proposed regulations implementing these provisions this summer.
The AACU believes that urologic patients should have access to beneficial therapies without interruption and submitted comments on behalf of our members and patients related to this issue.
More Recent AACU News
The Silent Epidemic: AACU and Man vs Prostate Call for a National Pivot Toward Bladder Health
The American Association of Clinical Urology (AACU), in a strategic partnership with Wayne Kuang, MD, and the Man vs Prostate initiative, is calling for immediate national action to address what we have termed the "silent epidemic" of male bladder health. Although the...
AACU Supports the Legislative Spirt of the Break Up Medicine Act
For much of the past decade, the structure of the healthcare marketplace has shifted toward increasing vertical integration. Insurers, pharmacy benefit managers, provider groups, and supply chain entities have become more closely aligned under common ownership...
AACU Supports H.R. 7602 which Seeks to Establish an Office of Men’s Health within the Department of Health and Human Services
The American Association of Clinical Urology (AACU) publicly supports H.R. 7602 titled “State of Men’s Health Act” sponsored by Representative Troy Carter, (D-LA) and Representative Greg Murphy (R-NC).